2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribu
about
Mammario-arterial anastomosis versus aorto-arterial anastomosis as proximal anastomotic sites in coronary artery bypass surgery for patients with multivessel diseasePeriprocedural antithrombotic therapy during various types of percutaneous cardiovascular interventionsNo reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarctionOverview of the pharmacological challenges facing physicians in the management of patients with concomitant cardiovascular disease and chronic obstructive pulmonary diseaseDual antiplatelet therapy: optimal timing, management, and durationDouble or triple antithrombotic combination therapy in patients who need anticoagulation and antiplatelet therapy in parallelNoninvasive FFR derived from coronary CT angiography in the management of coronary artery disease: technology and clinical updateState of the art: Oral antiplatelet therapyExtracorporeal Membrane Oxygenation as a Bridge for Heart Failure and Cardiogenic ShockComparison between National Institute for Health and Care Excellence (NICE) and European Society of Cardiology (ESC) guidelines for the diagnosis and management of stable angina: implications for clinical practicePhysiologic Assessment of Coronary Artery Disease: Focus on Fractional Flow ReserveTo Revascularise or Not To Revascularise, That Is the Question: the Diagnostic and Management Conundrum of Ischaemic CardiomyopathyNew Approaches to the Role of Thrombin in Acute Coronary Syndromes: Quo Vadis Bivalirudin, a Direct Thrombin Inhibitor?Thrombus aspiration during primary percutaneous coronary intervention for acute myocardial infarction: A review of clinical evidence and guidelinesHemostatic management of patients undergoing ear-nose-throat surgeryBioresorbable vascular scaffold implantation in acute coronary syndromes: clinical evidence, tips and tricksAntiplatelet Therapy in Hemodialysis Patients Undergoing Percutaneous Coronary InterventionsCardioprotection by remote ischemic conditioning: Mechanisms and clinical evidencesQuality markers in cardiology: measures of outcomes and clinical practice--a perspective of the Spanish Society of Cardiology and of Thoracic and Cardiovascular SurgeryTreatment strategies for coronary in-stent restenosis: systematic review and hierarchical Bayesian network meta-analysis of 24 randomised trials and 4880 patientsClinical potential of vorapaxar in cardiovascular risk reduction in patients with atherosclerosisClinical utility of platinum chromium bare-metal stents in coronary heart diseaseA Meta-Analysis of Randomized Clinical Trials Comparing Shorter (Less or Equal Than 6 Months) and Longer (More or Equal Than 12 Months) Dual Anti-Platelet Therapy Following Drug-Eluting Coronary StentsComing safely to a stop: a review of platelet activity after cessation of antiplatelet drugsEverolimus-eluting stent platforms in percutaneous coronary intervention: comparative effectiveness and outcomesMyocardial viability as integral part of the diagnostic and therapeutic approach to ischemic heart failure.Prognostic significance of infarct core pathology revealed by quantitative non-contrast in comparison with contrast cardiac magnetic resonance imaging in reperfused ST-elevation myocardial infarction survivors.Role of cardiovascular magnetic resonance in the guidelines of the European Society of Cardiology.Intracoronary Imaging in the Detection of Vulnerable Plaques.Extracorporeal life support during cardiac arrest and cardiogenic shock: a systematic review and meta-analysisAntithrombotic management in patients with percutaneous coronary intervention requiring oral anticoagulationThe Cost Effectiveness of LAA ExclusionUnderstanding and managing in-stent restenosis: a review of clinical data, from pathogenesis to treatmentDoes thrombo-aspiration still have a place in the treatment of myocardial infarction?Ischaemic stroke and ST-segment elevation myocardial infarction: fast-track single-stop approachCurrent developments and future applications of intracoronary hemodynamics2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of thePerspectives on the 2014 ESC/EACTS Guidelines on Myocardial Revascularization : Fifty Years of Revascularization: Where Are We and Where Are We Heading?Early Clinical Experience with a Polymer-Free Biolimus A9 Drug-Coated Stent in DES-Type Patients Who Are Poor Candidates for Prolonged Dual Anti-Platelet TherapyOutcomes of ≤6-month versus 12-month dual antiplatelet therapy after drug-eluting stent implantation: A meta-analysis and meta-regression.
P2860
Q24186682-F011117B-4149-4417-B2D0-60B428027753Q26740181-CEDA5AC0-A030-478B-8B81-CDBCF6C2E1C9Q26740252-B6EECD87-3731-4F9F-82BC-28E7B413EFC3Q26741051-46F65CA7-4C58-4A5A-8574-519B4B340E61Q26741055-D817F6DE-5DB3-4181-96A8-6E7B312E2013Q26741058-6ED60201-7ECE-4B4A-925B-B26088A2D25DQ26744342-FE4E630B-D940-4DDB-9EED-AF5D393BC922Q26746161-4F9A43D8-38C1-4D83-A534-45F855C5E3D3Q26746652-DA6AD777-8235-4614-9F14-1F4129AAFDE9Q26747599-7DC4CF38-2258-4678-A037-9F5765822FC1Q26748665-AD654ECE-6177-4F78-9885-68AE2DA9215EQ26749674-31DC13AD-E8E3-4D1B-BBD6-8140441EA5F5Q26765488-31B9F41D-7C8C-4E9B-B7D8-46E4F674F235Q26771115-5BDD911B-7B15-4034-81ED-A11FF7C3CBAAQ26771864-1646B696-C518-4320-878A-D2FDBC3DBB72Q26775130-30D5E783-F6BA-4CFD-89B8-F5F12DC395FEQ26777116-7C1AB84C-F912-4AD6-817A-45C7A29EB71EQ26777868-ADAF68F6-FFBA-4277-9C0A-09BC24B06525Q26778567-CD136C8B-36A6-40B6-81FB-A55E9EE4F3AFQ26780172-83B370A6-ACBA-45CF-B1DE-8D02C5C991DDQ26783034-553CD608-A8DB-4DBE-98E4-C7B5E5A10924Q26783440-2D4D96ED-8853-46E6-B168-F298CDA41EB5Q26784131-FE607719-2736-4137-ABDC-BC19A745988DQ26795403-2D308DC1-CE75-4B25-9BF1-606784BE3215Q26798582-C27FF426-6F3C-488E-8B31-5508D8573060Q26865768-C8335244-6A35-4712-A294-4C187598DBA1Q27301966-696BD095-68AF-4FC7-82D2-406A0A4E8E5AQ28069234-834D962A-937C-4936-BA80-E7FB0DD0E9A6Q28070042-AF2C90B7-2D8F-4611-A970-CE76FC760075Q28071264-0884A0D7-0D01-499A-B9EA-C0A5405358E2Q28072522-CEBE743F-2484-404B-BEB3-32CCFCE6B386Q28072579-B216F6CF-1D65-4C1B-BC74-C300E9E13A57Q28073031-2D22EB6F-2A31-4B0A-9298-A6D559C622E9Q28075687-61224D82-2BFA-40D6-A6B9-56E63EE163EEQ28082597-A5B8BC95-8082-4BBC-BADD-ACE76CDA8CE1Q28083138-9588312B-2DDD-423B-988C-CC4517734382Q28087002-787036CD-858B-4B60-97E8-D594C65B46B1Q28087099-A96576D6-8BD7-4B29-B5B8-BF0ED382712FQ28552288-D7D124EA-D9D5-4A40-BEB4-D50430EF6978Q30239889-A4A2F18F-7D92-4E7F-B66A-7D191EA800F9
P2860
2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribu
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
2014 ESC/EACTS Guidelines on m ...... oped with the special contribu
@en
2014 ESC/EACTS Guidelines on m ...... European Society of Cardiology
@nl
type
label
2014 ESC/EACTS Guidelines on m ...... oped with the special contribu
@en
2014 ESC/EACTS Guidelines on m ...... European Society of Cardiology
@nl
prefLabel
2014 ESC/EACTS Guidelines on m ...... oped with the special contribu
@en
2014 ESC/EACTS Guidelines on m ...... European Society of Cardiology
@nl
P2093
P50
P356
P1476
2014 ESC/EACTS Guidelines on m ...... oped with the special contribu
@en
P2093
A Pieter Kappetein
Adam Witkowski
Authors/Task Force members
Christian Hamm
David Paul Taggart
Dimitrios J Richter
Fernando Alfonso
Franz-Josef Neumann
Günther Laufer
Jean-Philippe Collet
P304
P356
10.1093/EURHEARTJ/EHU278
P50
P577
2014-08-29T00:00:00Z